Skip to main content
ILYANG PHARMACEUTICAL CO.,LTD logo

ILYANG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 007570 ISIN · KR7007570005 KO Manufacturing
Open in API
Filings indexed 225 across all filing types
Latest filing 2021-07-15 Director's Dealing
Country KR South Korea
Listing KO 007570

About ILYANG PHARMACEUTICAL CO.,LTD

https://www.ilyang.co.kr

Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share ownership and changes in holdings by a company executive (Kim Dong-yeon of ILYANG PHARMACEUTICAL CO., LTD.). This type of filing is specifically categorized as 'Director's Dealing' (DIRS) in the provided taxonomy, as it reports personal share transactions by company directors and executives.
2021-07-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used by major shareholders (such as the National Pension Service) to disclose changes in their equity stake in a listed company (Il-Yang Pharmaceutical). This falls under the category of Major Shareholding Notification.
2021-07-02 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Ilyang Pharm Co., Ltd. for the first quarter of the 51st fiscal year (2021-01-01 to 2021-03-31). It contains comprehensive financial statements, business descriptions, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-13 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Yang Pharmaceutical. It details specific share transactions (purchases) made by a major shareholder (Jung Jae-hoon) and provides a summary of the total shareholding status of the major shareholders. This type of filing is a standard regulatory disclosure regarding changes in ownership by insiders or major shareholders, which falls under the 'Major Shareholding Notification' category.
2021-05-10 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Changes in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Yang Pharmaceutical. It details specific transactions (purchases) made by a major shareholder (related party) and updates the total shareholding status of the major shareholders. This type of filing is a standard regulatory disclosure regarding significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2021-05-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations, including transaction dates, methods, and purposes. This falls under the category of Major Shareholding Notification.
2021-04-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.